Pharma News

1 May 2023

FDA approves treatment of amyotrophic lateral sclerosis associated with a mutation in the SOD1 gene

Action
FDA approved Qalsody (tofersen) to treat patients with amyotrophic lateral sclerosis (ALS) associated with a mutation in the superoxide dismutase 1 (SOD1) gene (SOD1-ALS). Qalsody is an antisense oligonucleotide that targets SOD1 mRNA to reduce the synthesis of SOD1 protein. The approval was based on a reduction in plasma neurofilament light (NfL), a blood-based biomarker of axonal (nerve) injury and neurodegeneration.

1 May 2023

Study unlocks potential breakthrough in Type 1 diabetes treatment

For the over 8 million people around the globe living with Type 1 diabetes, getting a host immune system to tolerate the presence of implanted insulin-secreting cells could be life-changing.

Rice University bioengineer Omid Veiseh and collaborators identified new biomaterial formulations that could help turn the page on Type 1 diabetes treatment, opening the door to a more sustainable, long-term, self-regulating way to handle the disease.

1 May 2023

New test reveals existing antibiotics, hiding in plain sight on pharmacy shelves, can cure superbugs

A new test revealed that FDA-approved antibiotics available at your neighborhood pharmacy can effectively treat superbugs. They are not prescribed, however, because the gold-standard test predicts they will not work. The new test may improve the way antibiotics are developed, tested and prescribed and it is openly available to all.

27 April 2023

Venus remedies receives MHRA nod for marketing of Cisplatin

This marketing authorisation granted to Venus Pharma GmbH, the German subsidiary of Venus Remedies, by one of the world’s most stringent healthcare regulatory agencies will enable the company to offer its affordable range of cancer drugs to the National Health Service (NHS) in the UK and neighbouring countries.

27 April 2023

IPCA to acquire 33 percent holdings in Unichem for 1034 crore

Ipca Laboratories to acquire 33.38 percent shares in Unichem Laboratories for Rs 1034.06 Crores. Ipca Laboratories announced that the company has entered into a definitive Share Purchase Agreement (SPA) for acquisition of 2,35,01,440 fully paid-up equity shares of Rs. 21- each, constituting 33.38% of the paid up equity share capital of Unichem Laboratories Ltd. (Unichem), from one of its promoter shareholder at a price at Rs. 440 per equity share aggregating to Rs; 1034.06 Crores.

27 April 2023

A newly fabricated bio-electronic uric acid detecting device can be used for wearable sensors and point-of-care diagnostics

A new flexible bio-electronic uric acid detecting device has been fabricated that can be used for various applications such as wearable sensors and point-of-care diagnostics.

27 April 2023

Cabinet approves the Policy for the Medical Devices Sector

The Union Cabinet, chaired by the Hon'ble Prime Minister Shri Narendra Modi, today approved the National Medical Devices Policy, 2023.

26 April 2023

Arterial stiffness may cause metabolic syndrome in adolescents via an increase in fasting insulin and LDL-cholesterol

Arterial stiffness may be a novel risk factor for metabolic syndrome in teens, a paper published in the American Journal of Physiology-Heart and Circulatory Physiology concludes. The study was conducted in collaboration between the University of Bristol in the UK, the University of Exeter in the UK, and the University of Eastern Finland.

26 April 2023

Iptacopan improves hemoglobin to near-normal levels in PNH patients

Research molecule of Novartis, Iptacopan improves hemoglobin to near-normal levels, leading to transfusion independence in all treatment-naive paroxysmal nocturnal hemoglobinuria patients, as per recent trials.

The trial met its primary endpoint and demonstrated clinically meaningful benefits across secondary endpoints. These data were presented at the 49th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT).